This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11110%2F09%3A3451%21RIV10-MSM-11110___/
n13http://localhost/temp/predkladatel/
n5http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n11http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n14http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11110%2F09%3A3451%21RIV10-MSM-11110___
rdf:type
skos:Concept n11:Vysledek
dcterms:description
There is our observation regarding the combination of antiviral agents and antithrombin III concentrate that could be beneficial in the fulminant course of SAHB in the future. There is our observation regarding the combination of antiviral agents and antithrombin III concentrate that could be beneficial in the fulminant course of SAHB in the future.
dcterms:title
Favorable Outcome of Severe Acute Hepatitis B in a Patient Treated with Antithrombin III and Antiviral Therapy Favorable Outcome of Severe Acute Hepatitis B in a Patient Treated with Antithrombin III and Antiviral Therapy
skos:prefLabel
Favorable Outcome of Severe Acute Hepatitis B in a Patient Treated with Antithrombin III and Antiviral Therapy Favorable Outcome of Severe Acute Hepatitis B in a Patient Treated with Antithrombin III and Antiviral Therapy
skos:notation
RIV/00216208:11110/09:3451!RIV10-MSM-11110___
n4:aktivita
n9:V
n4:aktivity
V
n4:cisloPeriodika
3
n4:dodaniDat
n14:2010
n4:domaciTvurceVysledku
n5:5649617 n5:6737374
n4:druhVysledku
n10:J
n4:duvernostUdaju
n7:S
n4:entitaPredkladatele
n12:predkladatel
n4:idSjednocenehoVysledku
314761
n4:idVysledku
RIV/00216208:11110/09:3451
n4:jazykVysledku
n15:eng
n4:klicovaSlova
lamivudine; severe acute hepatitis B; antithrombin III; venous thromboembolism; methylenetetrahydrofolate reductase; fulminant course
n4:klicoveSlovo
n8:venous%20thromboembolism n8:lamivudine n8:severe%20acute%20hepatitis%20B n8:antithrombin%20III n8:methylenetetrahydrofolate%20reductase n8:fulminant%20course
n4:kodStatuVydavatele
US - Spojené státy americké
n4:kontrolniKodProRIV
[F1B54BAF2181]
n4:nazevZdroje
Clinical Infectious Diseases
n4:obor
n17:FN
n4:pocetDomacichTvurcuVysledku
2
n4:pocetTvurcuVysledku
2
n4:rokUplatneniVysledku
n14:2009
n4:svazekPeriodika
49
n4:tvurceVysledku
Holub, Michal Chalupa, Pavel
n4:wos
000267819700030
s:issn
1058-4838
s:numberOfPages
1
n13:organizacniJednotka
11110